PRGO Q1 2019 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B-3.5% YoY

Gross Profit

$449M38.2% margin

Operating Income

$102M8.7% margin

Net Income

$64M5.4% margin

EPS (Diluted)

$0.47

QoQ Revenue Growth

-1.7%

Cash Flow

Operating Cash Flow

$95M

Free Cash Flow

$73M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$11.1B

Total Liabilities

$5.4B

Stockholders' Equity

$5.7B

Cash & Equivalents

$838M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	-3.5%
Gross Profit	$449M	$493M	-8.9%
Operating Income	$102M	$156M	-34.5%
Net Income	$64M	$81M	-20.9%

Revenue Segments

Consumer Self-Care Americas

$582M50%

Consumer Self-Care International

$351M30%

RX Pharmaceuticals

$242M21%

Geographic Segments

UNITED STATES

$769M65%

Europe

$341M29%

Other Geographical Areas

$65M5%

IRELAND

$5M0%